News

24/7 Wall St. on MSN3h
Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...
MedPage Today on MSN13d
RFK Jr.'s Purge of FOIA Staff at FDA Spares People Working on COVID Vaccine Lawsuits
"FDA FOIA staff, including those working on litigation involving CBER, were impacted as part of HHS' reorganization," Nixon ...
Pfizer: Tasty 7% Yield
Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...
STAT7d
Vaccine advisory panel recommends expanded RSV use, and two new vaccines
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
Fierce Pharma7d
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
PharmExec6d
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to ...
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight Loss Pill?
In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...